Peripheral blood markers predict prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy
Peng Zhang, Peng Cao, Shanyue Tan, Ling Xu · 2026
Read Peripheral blood markers predict prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy by Peng Zhang, Peng Cao, Shanyue Tan, Ling Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619245.txt.
Description
Zhang P, Cao P, Tan S, and Xu L asked whether simple blood tests taken before treatment can predict how patients with advanced non-small cell lung cancer will fare on immunotherapy. They reviewed records for 139 patients treated between 2019 and 2022 and compared baseline blood values with survival and time before the cancer grew. Statistical models were used to find which markers predicted outcomes on their own.
Two markers stood out: C-reactive protein and carcinoembryonic antigen each predicted both survival and time without growth. High platelet counts and low albumin also pointed to worse outcomes, and certain cut-off values split patients into better and worse groups. Used together, the two main markers predicted outcomes with moderate accuracy. The authors suggest these cheap, routine tests could help doctors judge likely benefit before treatment starts.
Catalog record
| CREATOR | Peng Zhang, Peng Cao, Shanyue Tan, Ling Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |